Recap: Cardlytics Q3 Earnings
Portfolio Pulse from Benzinga Insights
Cardlytics (NASDAQ:CDLX) reported its Q3 earnings with an in-line EPS of $-0.01, matching the estimate. Revenue was up $6.30 million from the same period last year. Last quarter, the company beat the EPS estimate by $0.19, which led to a 19.79% increase in the share price the next day.

November 08, 2023 | 9:25 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cardlytics reported Q3 earnings in line with estimates, and a YoY revenue increase. Previous EPS beat led to a significant share price increase.
Cardlytics reported its Q3 earnings in line with estimates, which is a neutral signal for the market. However, the company's revenue was up $6.30 million from the same period last year, which is a positive signal. In the previous quarter, the company's EPS beat led to a 19.79% increase in the share price the next day, indicating that the market reacts strongly to Cardlytics' earnings reports. Therefore, this earnings report could have a significant impact on the company's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100